Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer

Culver City, CA (PRWEB) April 28, 2015 A first-in-human prostate cancer study released today in the Journal of Molecular Imaging and Biology showed initial safety, biodistribution, and dosimetry results with [18F]DCFPyL, a 2nd generation fluorine-18 labeled small-molecule PSMA inhibitor. The imaging biomarker has been developed at Johns Hopkins University in Baltimore, MD by study co-author, ...

Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer

(PRWEB) December 22, 2014 The American Journal of Hematology/Oncology, a monthly peer-reviewed publication of original research, reviews and editorials addressing developments and pathways related to oncological science and clinical practice, today published a provocative article exploring the role of follicle-stimulating hormone (FSH) in the development, progression and potential treatment of prostate cancer. The article ...